Alan K. Meeker, Ph.D.
Affiliations: | 2001 | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Cell BiologyGoogle:
"Alan Meeker"Mean distance: 11375.1
Parents
Sign in to add mentor| Donald S. Coffey | grad student | 2001 | Johns Hopkins | |
| (Telomere dynamics and androgen regulation of telomerase enzymatic activity in normal and pathological states of the prostate.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pinto LM, Pailas A, Bondarchenko M, et al. (2023) DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. Nucleic Acids Research |
| Mori JO, Elhussin I, Brennen WN, et al. (2023) Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews. Urology |
| Heaphy CM, Joshu CE, Barber JR, et al. (2022) The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy. The Journal of Pathology. Clinical Research |
| Li QK, Chen J, Hu Y, et al. (2021) Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors. Scientific Reports. 11: 18936 |
| Zhan D, Ma D, Wei S, et al. (2021) Monoallelic IDH1 R132H mutation mediates glioma cell response to anti-cancer therapies via induction of senescence. Molecular Cancer Research : McR |
| Shrestha E, Coulter JB, Guzman W, et al. (2021) Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Zhu Y, Dalrymple SL, Coleman I, et al. (2021) Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors. Oncogene |
| Brennen WN, Zhu Y, Coleman IM, et al. (2021) Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer. Jci Insight |
| Zhu Y, Dalrymple SL, Coleman I, et al. (2021) Correction to: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors. Oncogene |
| Joshu CE, Heaphy CM, Barber JR, et al. (2020) Obesity is associated with shorter telomere length in prostate stromal cells in men with aggressive prostate cancer. Cancer Prevention Research (Philadelphia, Pa.) |